- Home
- ELVN vs STAA Comparison
ELVN vs STAA Comparison
Compare ELVN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- STAA
- Stock Information
- Founded
- ELVN 2016
- STAA 1982
- Country
- ELVN United States
- STAA United States
- Employees
- ELVN N/A
- STAA N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- ELVN Health Care
- STAA Health Care
- Exchange
- ELVN Nasdaq
- STAA Nasdaq
- Market Cap
- ELVN 927.8M
- STAA 850.9M
- IPO Year
- ELVN 2020
- STAA N/A
- Fundamental
- Price
- ELVN $20.73
- STAA $17.86
- Analyst Decision
- ELVN Strong Buy
- STAA Hold
- Analyst Count
- ELVN 5
- STAA 8
- Target Price
- ELVN $41.20
- STAA $27.17
- AVG Volume (30 Days)
- ELVN 747.2K
- STAA 814.8K
- Earning Date
- ELVN 08-12-2025
- STAA 08-06-2025
- Dividend Yield
- ELVN N/A
- STAA N/A
- EPS Growth
- ELVN N/A
- STAA N/A
- EPS
- ELVN N/A
- STAA N/A
- Revenue
- ELVN N/A
- STAA $279,134,000.00
- Revenue This Year
- ELVN N/A
- STAA N/A
- Revenue Next Year
- ELVN N/A
- STAA $29.34
- P/E Ratio
- ELVN N/A
- STAA N/A
- Revenue Growth
- ELVN N/A
- STAA N/A
- 52 Week Low
- ELVN $13.30
- STAA $13.50
- 52 Week High
- ELVN $30.03
- STAA $49.86
- Technical
- Relative Strength Index (RSI)
- ELVN 52.08
- STAA 55.08
- Support Level
- ELVN $19.22
- STAA $16.40
- Resistance Level
- ELVN $21.90
- STAA $17.24
- Average True Range (ATR)
- ELVN 1.49
- STAA 0.66
- MACD
- ELVN -0.19
- STAA 0.13
- Stochastic Oscillator
- ELVN 39.43
- STAA 91.76
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.